Cargando…
Weight Loss Outcomes Among Early High Responders to Exenatide Treatment: A Randomized, Placebo Controlled Study in Overweight and Obese Women
OBJECTIVE: As there is significant heterogeneity in the weight loss response to pharmacotherapy, one of the most important clinical questions in obesity medicine is how to predict an individual’s response to pharmacotherapy. The present study examines patterns of weight loss among overweight and obe...
Autores principales: | Rodgers, Megan, Migdal, Alexandra L., Rodríguez, Tahereh Ghorbani, Chen, Zsu-Zsu, Nath, Anjali K., Gerszten, Robert E., Kasid, Natasha, Toschi, Elena, Tripaldi, Juliet, Heineman, Brent, Phan, Minh, Ngo, Long, Maratos-Flier, Eleftheria, Dushay, Jody |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635796/ https://www.ncbi.nlm.nih.gov/pubmed/34867786 http://dx.doi.org/10.3389/fendo.2021.742873 |
Ejemplares similares
-
Short-Term Exenatide Treatment Leads to Significant Weight Loss in a Subset of Obese Women Without Diabetes
por: Dushay, Jody, et al.
Publicado: (2012) -
Fructose ingestion acutely stimulates circulating FGF21 levels in humans
por: Dushay, Jody R., et al.
Publicado: (2014) -
Fibroblast growth factor 21 and fructose dynamics in humans
por: Migdal, A., et al.
Publicado: (2018) -
Elevated Serum Fibroblast Growth Factor 21 in Humans with Acute Pancreatitis
por: Shenoy, Vivek K., et al.
Publicado: (2016) -
Surface Electrical Impedance Myography Detects Skeletal Muscle Atrophy in Aged Wildtype Zebrafish and Aged gpr27 Knockout Zebrafish
por: Rutkove, Seward B., et al.
Publicado: (2023)